Tympanogen, Inc.
- UEI
- W8RKQ5AJK6G6
- CAGE
- 72LC5
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Tympanogen's DHA sbir 19.2 phase i medical r & d purchase order from proposal H192-006-0002 for "a novel GEL material… | Medical Command (Army) | $249,963 |
Grant awards
Similar vendors
About the company
Tympanogen, Inc., doing business as Tympanogen Inc., is a self-certified small disadvantaged, woman-owned small business registered to receive federal contract and grant awards. The company develops medical devices and therapeutics, with a focus on treatments for ear conditions and hearing loss.
Through a prime federal contract award from the Defense Health Agency, Tympanogen received a Small Business Innovation Research (SBIR) Phase I contract for the development of "A Novel Gel Material for Rapid, Point-of-Need Tympanic Membrane Repair." This firm fixed-price purchase order, valued at $249,963.32, was set aside for small businesses and had a completion date of July 15, 2020. The contract aimed to advance Tympanogen's research into a nonsurgical gel patch for repairing perforated eardrums.
Tympanogen has also received two prime federal grant awards from the National Institute on Deafness and Other Communication Disorders, a part of the National Institutes of Health. The first grant, worth $3,235,980.00, supports a clinical study to enable the commercialization of Tympanogen's nonsurgical gel patch for eardrum repair, with a planned submission to the FDA for clearance as a Class II medical device. The second grant, valued at $1,479,163.00, funds the development of the gel patch as a potential replacement for surgical eardrum repair procedures.
Quick answers
Is Tympanogen, Inc. registered in SAM.gov?
Tympanogen, Inc.'s SAM.gov registration expired on February 25, 2026.
What is Tympanogen, Inc.'s most recent federal award?
Tympanogen, Inc.'s most recent federal contract award is Tympanogen's DHA sbir 19.2 phase i medical r & d purchase order from proposal H192-006-0002 for "a novel GEL material… (W81XWH20P0013), from Medical Command (Army), on December 16, 2019.
On GovTribe
See Tympanogen, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors